膝骨关节炎患者血清和关节液中MMP-13和TNF-α水平的变化意义

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (555 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the changes of matrix metalloproteinases 13 (MMP-13), TNF-α in serums and synovial fluids of patients with knee osteoarthritis (KOA). Methods From May 2014 to May 2016, in Traditional Chinese Medicine Hospitals of Chengde, 84 patients with KOA and 80 healthy persons (control group) were selected, according to Kellgren & Lawrence (K-L) grading, they were divided into KOA 1~2 (n = 45) and KOA 3~4 (n = 39). the levels of TNF-α, MMP-13 in the serums and synovial fluids were measures by ELISA. Results The WOMAC score of KOA 3～4 patients was higher than KOA1～2 patients, the difference was statistically significant (P < 0.05); the levels of TNF-α, MMP-13 in serum and synovial fluid of KOA 3～4 patients were higher than KOA 1～2 patients, the differences were statistically significant (P < 0.05). the level of MMP-13 in serum and synovial fluid of KOA 1～2 patients were higher than control group, the differences were statistically significant (P < 0.05), but there was no statistically significant difference in the TNF-α levels (P > 0.05). The level of MMP-13 in serum of KOA patients was higher than synovial fluid, the difference was statistically significant (P < 0.05), but there was no statistically significant difference in TNF-α levels (P > 0.05). Correlation analysis showed that the serum and synovial fluid levels of MMP-13 in KOA patients were positively correlated with WOMAC score (r = 0.599, 0.641, P < 0.05), but the serum and synovial fluid levels of TNF-α in KOA patients were no correlated with WOMAC score (P > 0.05). Conclusion The serum and synovial fluids levels of TNF-α and MMP-13 elevate in KOA patients, and then MMP-13 levels show correlation with WOMAC scores.

Key words： Knee osteoarthritis Tumor necrosis factor-α Matrix metalloproteinases-13 Cytokines

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Lei1 DONG Hong2 KONG Jichang3 Yang Jihong4

Cite this article:

WANG Lei1 DONG Hong2 KONG Jichang3 Yang Jihong4. Significances of changes of matrix metalloproteinases-13, TNF-α in serums and synovial fluids of patients with knee osteoarthritis[J]. 中国医药导报, 2017, 14(15): 98-101.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2017/V14/I15/98

[1] Thiam D，Teh DJ，Bin Abd Razak HR，et al. Improvement in health-related quality of life after unilateral total knee arthroplasty in patients with bilateral knee osteoarthritis [J]. J Orthop Surg （Hong Kong），2016，24（3）：294-297.
[2] Felson DT. Intra-articular corticosteroids and knee osteoarthritis：interpreting different meta-analyses [J]. JAMA，2016， 316（24）：2607-2608.
[3] Nishimura A，Hasegawa M，Kato K，et al. Risk factors for the incidence and progression of radiographic osteoarthritis of the knee among Japanese [J]. Int Orthop，2011，35（6）：839-843.
[4] Dias CN，Vasilceac FA，Durigan JL，et al. Analysis of local and systemic TNF-α and IL1-α expression in the acute phase of knee osteoarthritis of rats [J]. Cytokine，2014， 66（2）：164-165.
[5] Santangelo KS，Nuovo GJ，Bertone AL，et al. In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis [J]. Osteoarthritis Cartilage，2012，20（12）：1610-1618.
[6] Sakthivel KM，Guruvayoorappan C. Acacia ferruginea inhibits tumor progression by regulating inflammatory mediators-（TNF-α，iNOS，COX-2，IL-1β，IL-6，IFN-γ，IL-2，GM-CSF） and pro-angiogenic growth factor- VEGF [J]. Asian Pac J Cancer Prev，2013，14（6）：3909-3919.
[7] MacFarlane RJ，Graham SM，Davies PS，et al. Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases：potential for treatment [J]. Expert Opin Ther Targets，2013，17（3）：243-254.
[8] Santangelo KS，Nuovo GJ，Bertone AL. In vivo reduction or blockade of interleukin-1β in primary osteoarthritis influences expression of mediators implicated in pathogenesis [J]. Osteoarthritis Cartilage，2012，20（12）：1610-1618.
[9] Wang W，Kang W，Tang Q，et al. Cilostazol prevents the degradation of collagen type II in human chondrocytes [J]. Biochem Biophys Res Commun，2014，451（3）：352-355.
[10] Zhang X，Zhu Y，Chen X，et al. Baicalein ameliorates inflammatory-related apoptotic and catabolic phenotypes in human chondrocytes [J]. Int Immunopharmacol，2014，21（2）：301-308.
[11] Alelaha D，Neogi T，Silman AJ，et al. 2010 rheumatoid arthritis classification criteria [J]. Arthritis Rheum，2010， 62（9）：2569-2581.
[12] Holzer N，Salvo D，Marijnissen AC，et al. Radiographic evaluation of posttraumatic osteoarthritis of the ankle：the Kellgren-Lawrence scale is reliable and correlates with clinical symptoms [J]. Osteoarthritis Cartilage，2015，23（3）：363-369.
[13] Preece SJ，Jones RK，Brown CA，et al. Reductions in co-contraction following neuromuscular re-education in people with knee osteoarthritis [J]. BMC Musculoskelet Disord，2016，17（1）：372.
[14] Wassilew GI，Lehnigk U，Duda GN，et al. The expression of proinflammatory cytokines and matrix metalloproteinases in the synovial membranes of patients with osteoarthritis compared with traumatic knee disorders [J]. Arthroscopy，2010，26（8）：1096-1104.
[15] Woodell-May J，Matuska A，Oyster M，et al. Autologous protein solution inhibits MMP-13 production by IL-1β and TNFα-stimulated human articular chondrocytes [J]. J Orthop Res，2011，29（9）：1320-1326.
[16] Ene R，Sinescu RD，Ene P，et al. Synovial inflammation in patients with different stages of knee osteoarthritis [J]. Rom J Morphol Embryol，2015，56（1）：169-173.
[17] Park SJ，Cheon EJ，Lee MH，et al. MicroRNA-127-5p regulates matrix metalloproteinase 13 expression and interleukin-1β-induced catabolic effects in human chondrocytes [J]. Arthritis Rheum，2013 ，65（12）：3141-3152.
[18] Aktas E，Sener E，Gocun PU. Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunomodulatory properties of simvastatin via inhibition of matrix metalloproteinase-3 [J]. J Orthop Traumatol，2011，12（3）：145-151.
[19] Rutgers M，Saris DB，Dhert WJ，et al. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis，in vitro effects on cartilage metabolism and intra-articular levels after injection [J]. Arthritis Res Ther，2010， 12（3）：R114.
[20] ?魻zler K，Akta?鬤 E，Atay，et al. Serum and knee synovial fluid matrixmetalloproteinase-13 and tumor necrosis factor-alpha levels in patients with late stage osteoarthritis [J]. Acta Orthop Traumatol Turc，2016，50（6）：670-673.